Current possibilities of diagnostics and treatment of immunological causes of female infertility
Authors:
Karin Malíčková 1,2; Zuzana Ambrusová 2,3; Slávka Belvončíková 4; Katarína Bergendiová 5; Zuzana Krátká 2; Martin Lešťan 4; Štěpánka Luxová 2; Jiří Novák 6; Elena Tibenská 7,8; Jana Vydláková 2,9; Lenka Sedláčková 2
Authors‘ workplace:
Klinické centrum ISCARE, a. s., Praha
1; Oddělení alergologie a klinické imunologie, GENNET, s. r. o., Praha
2; Ambulance pro alergologii a imunologii, Nemocnice s poliklinikou Mělník
3; Alergoimunologické centrum EMED, s. r. o., Prešov, SR
4; ImunoVital Centrum, Bratislava, SR
5; Centrum klinické imunologie, Nemocnice České Budějovice
6; MEDIREX, a. s., Bratislava, SR
7; Jednotka klinického výskumu, Lekárska fakulta Univerzity Komenského v Bratislave, SR
8; Ambulance klinické imunologie a alergologie, IKEM, Praha
9
Published in:
Čas. Lék. čes. 2021; 160: 5-13
Category:
Review Article
Overview
The immune system plays an important role in many processes of human reproduction. During pregnancy, mother's body has to accept the semialogenic fetus, therefore the role of immune processes has a high importance. Tolerance of the fetus by the mother's immune system is ensured by a complex of immune mechanisms, the knowledge of which brings us to the new insights into human reproduction processes and in seeking of new ways to modulate immunity in repeated embryo implantation failures, miscarriages, premature births, preeclampsia, and other fertility disorders and pregnancy complications. The review article is a summary of current possibilities of immunological laboratory diagnostics in reproductive immunology, presents indications for these tests and their interpretation, and mentions possible methods of therapeutic immune intervention.
Keywords:
infertility – Miscarriage – Immunity – In vitro fertilization – Autoantibodies – cellular immunity – NK cells – immunomodulation
Sources
1. Řežábek K, Pohlová R. Asistovaná reprodukce v České republice 2017. Ústav zdravotnických informací a statistiky ČR. Dostupné na: www.uzis.cz/ res/f/008274/asistreprodukce2017.pdf
2. Madar J, Ulčová-Gallová Z a kol. Imunologie a imunopatologie lidské reprodukce. Vybrané kapitoly. Mladá fronta, Praha, 2016: 113.
3. Hasegawa A, Tanaka H, Shibahara H. Infertility and Immunocontraception based on zona pellucida. Reprod Med Biol 2013; 13(1): 1-9.
4. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet 2010; 27: 519-524.
5. Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol 2015; 13: 34.
6. Sharif K, Watad A, Bridgewood C et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab 2019; 33(6): 101323.
7. van Weissenbruch MM, Hoek A, van Vliet-Bleeker I et al. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab 1991; 73: 360-367.
8. Buliková A, Zavřelová J, Penka M. Antifosfolipidový syndrom v roce 2009. Vnitřní lékařství 2009; 55: 253–262.
9. Ulčová-Gallová Z. Antiphospholipid antibodies and reproductive failure. Chem Immunol Allergy 2005; 88: 139-149.
10. Bulíková A, Smejkal P, Kissová J a kol. Profylaxe a léčba antifosfolipidového syndromu – současné možnosti, úskalí a perspektivy do budoucna. Vnitřní lékařství 2012; 58: 110-122.
11. Dobrowolski C, Erkan D. Treatment of antiphospholipid syndrome beyond anticoagulation. Clin Immunol 2019; 206: 53-62.
12. Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. Garamon, Hradec Králové, 2016: 274-276.
13. Eliakim R, Sherer DM. Celiac disease: fertility and pregnancy. Gynecol Obstet Invest 2001; 51: 3-7.
14. Frič P, Keil R. Celiakie pro praxi. Medicína pro praxi 2011; 8(9): 354-359.
15. Di Simone N, Silano M, Castellani R et al. Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro. Am J Gastroenterol 2010; 105: 2254-2261.
16. Lukáš K, Hroch J. Nemoci střev. Grada, Praha, 2018, 128-130.
17. Lochman I, Martinek J. Titrace autoprotilátek detekovaných metodami nepřímé imunofluorescence (IIFA). Alergie 2010; (4): 294-296.
18. Tomek V, Gilík J, Kovanda J a kol. Prenatální diagnostika kardiálního postižení u lupus neonatorum. Česká revmatologie 2019, 27(3): 136-141
19. Marek J, Hána V a kol. Endokrinologie. Galén, Praha, 2017: 201-220.
20. Zhu, L. Wu, B. Xu G et al. A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment. Reprod Biol Endocrinol 2013; 11: 98.
21. Lukeš J, Koranda P. Laboratorní diagnostika onemocnění štítné žlázy. Interní medicína pro praxi. 2001; 3: 120-123.
22. Vrbíková J. Syndrom polycystických ovarií. Vnitřní lékařství 2015; 61(10): 886-895.
23. Busnelli A, Paffoni A, Fedele L et al. The impact of thyroid autoimmunity on IVF/ICSI outcome: a systematic review and meta-analysis. Hum Reprod Update. 2016; 22(6): 775-790.
24. Springer D, Límanová Z, Zima T, Calda P. Vyšetření funkce štítné žlázy v těhotenství – naše výsledky. Aktuální gynekologie a porodnictví 2009; 1: 50-54.
25. Límanová Z, Jiskra J, Springer D a kol. Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility. Praktická gynekologie 2013; 17(2): 173-199.
26. Řezáčová J et al. Reprodukční medicína. Mladá fronta, Praha, 2018: 497-498.
27. Barbonetti A, Castellini C, D'Andrea S et al. Prevalence of anti-sperm antibodies and relationship of degree of sperm auto-immunization to semen parameters and post-coital test outcome: a retrospective analysis of over 10 000 men. Hum Reprod 2019; 34(5): 834-841.
28. Skalníková H, Freiberger T, Chumchalová J et al. Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods 2004; 295(1-2): 139-147.
29. Koucký M, Malíčková K, Kopřivová H et al. Low maternal serum concentrations of mannose-binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight. Scand J Immunol 2018; 88(1): e12675.
30. Pařízek A, Koucký M, Dušková M. Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol 2014; 139: 159-165.
31. Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res 2010; 125(5): e240-e245.
32. Buc M. NK- a NKT-bunky – ich charakteristika, biologický a medicínsky význam. MEFANET LF UK v Bratislave, 2013. Dostupné na: portal.fmed.uniba. sk/clanky.php?aid=223
33. Ebina Y, Nishino Y, Deguchi M et al. Natural killer cell activity in women with recurrent miscarriage: Etiology and pregnancy outcome. J Reprod Immunol 2017; 120: 42-47.
34. Karami N, Boroujerdnia MG, Nikbakht R et al. Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol 2012; 95(1-2): 87-92.
35. Malíčková K, Koucký M, Vráblíková H. T-lymfocyty ve fyziologické a patologické graviditě. Alergie 2014; 2: 115-121.
36. Saito S, Tomoko S, Kumiko I et al. Which types of regulatory T cells play important roles in implantation and pregnancy maintenance. Am J Reprod Immunol 2013; 69(4): 340-345.
37. Faas MM, de Vos P. Uterine NK cells and macrophages in pregnancy. Placenta 2017; 56: 44-52.
38. Kofod L, Lindhard A, Hviid TVF. Implications of uterine NK cells and regulatory T cells in the endometrium of infertile women. Hum Immunol 2018; 79(9): 693-701.
39. Ulčová-Gallová Z, Pešek M, Chaloupka P et al. Screeningové vyšetření endometriálních NK buněk u vybraných infertilních pacientek 1. část – metodika a průběžné výsledky. Česká gynekologie 2017; 82(5): 366-371.
40. Hannan NJ, Nie G, Rainzcuk A et al. Uterine lavage or aspirate: which view of the intrauterine environment? Reprod Sci 2012; 19(10): 1125-1132.
41. Arora R, Rathee A, Sachdeva M et al. Unexplained repeated pregnancy loss and T helper cells. Eur J Obstet Gynecol Reprod Biol 2020; 254: 277-283.
42. Wang W, Sung N, Gilman-Sachs A et al. T helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells. Front Immunol 2020; 11: 2025.
43. Horká P, Jarošová R, Malíčková K et al. Intracellular cytokine production in peripheral blood lymphocytes: a comparison of values in infertile and fertile women. Am J Reprod Immunol 2011; 65(5): 466-469.
44. Instruction NKFlowEx Kit, REF ED7078. Exbio Diagnostics. Dostupné na: www.exbio.cz/clinical-products/reproductive-immunology/kits/nkflowex-kit
45. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4(2): 295-306.
46. Bradwell AR, Hughes RG, Karim AR. Immunofluorescent antinuclear antibody tests. In: Manual of Clinical Laboratory Immunology (7th ed.). ASM Press, 2006.
47. Řezáčová J a kol. Reprodukční medicína. Mladá fronta, Praha, 2018: 505-522.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
2021 Issue 1
Most read in this issue
- Circulating NK and NKT cells in the diagnosis and treatment of immunological causes of female infertility – retrospective data analysis from the tertiary clinical center
- Current possibilities of diagnostics and treatment of immunological causes of female infertility
- Diagnostics of infertile males in the 21st century – a traditional concept or a modern approach?
- Conspiracy theories as a natural part of pandemics